Market Research Blog

Inflammatory markers are used in the assessment of cancer and other chronic diseases. Inflammation markers raise in the inflammatory conditions. C reactive protein and interleukin are the most common form of inflammatory markers.

Some of the common inflammatory conditions include rheumatoid arthritis, tissue injury and burns, Crohn’s disease, cancer, etc.

Introduction of an infectious organism including mycobacterium tuberculosis, protozoa, fungi, and other parasites that can resist host defenses and remain in the tissue for an extended period, is one of the major cause of chronic inflammation. Other causes of chronic inflammation include exposure to a low level of particular irritant and foreign particles, autoimmune diseases, in which the immune system is sensitized. Chronic inflammation can be caused due to repeated episodes of acute inflammation

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-10251

Inflammatory markers: Market Dynamics

Increasing prevalence of cancer is one of the major factors, responsible for the significant growth of inflammatory markers market. Increasing population especially in developing regions and increasing prevalence of other chronic diseases, is expected to increase the growth of inflammatory markers market. Increasing research and developmental activities is another important factor which can drive the growth of inflammatory markers market. Other factors such as increasing healthcare awareness, an increasing number of hospitals and research laboratories, etc. are expected to increase the growth of inflammatory markers market. Increasing government initiatives and increasing government funding for the research activities, is a very important factor which can increase the growth of inflammatory markers market. An increasing number of diagnostic laboratories is expected to increase the growth of global inflammation markers market.

There are a few factors, which can restrain the growth of inflammatory markers market. Lack of healthcare awareness in some of the emerging regions is expected to increase the growth of the global inflammatory markers market.

Global Inflammatory markers Market: Overview

Based on product type, inflammatory markers market has been segmented into interlukins, C reactive proteins, lepitine, cellular adhesion molecules, tumor necrosis factors and others. Interlukins are expected to hold a large revenue share in the global inflammatory markers market. Based on the indications, the global inflammatory markers market has been segmented into tumors, arthritis, multiple sclerosis, diabetes and various other applications. Tumors are expected to hold a large revenue share in the overall inflammatory markers market. Based on the end user, the inflammatory markers market has been segmented into hospitals, clinics, research laboratories and others. Research laboratories are expected to hold a significant share in the global inflammatory markers market.

Global Inflammatory markers Market: Region-wise Outlook

On the basis of geography, global inflammatory markers market is segmented into several key regions viz. North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East and Africa. North America is expected to hold the largest shares in the inflammatory markers market primarily due to presence of well-established healthcare infrastructure and the presence of large number of research laboratories Europe is expected to hold a large revenue share in Inflammatory markers market due to increasing population and increasing prevalence of chronic diseases. Asian countries are also expected to hold a significant growth rate in the forecast period due to increasing healthcare awareness among the people.

Inflammatory markers Market: Key Players

There are many companies manufacturing inflammatory markers. Some of the key players present in Global Inflammatory markers market are Merck and Co., Novartis International AG, Abnova, Cayman Chemical, Thermo Fisher Scientific, Cell Signaling Technology, Inc., Boditech Med Inc., LSI Medience Corporation, Abbott Diagnostics Inc., Siemens Healthcare Diagnostics Inc., BG Medicine Inc., LifeSign LLC.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-10251

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Antimicrobial Peptides are molecules that form part of host defense mechanism in prokaryotic as well as eukaryotic cells capable of protecting against the harmful infective threats modelled by the bacteria, viruses and even fungi.  The mode of action highly depends on the composition of antimicrobial peptides and hence utilized to target cytoplasmic membranes, cell walls, DNA and proteins. This makes antimicrobial peptides useful molecules to design assays, therapies and combination treatment via immunomodulation. The activation, elicitation and suppression of biological systems is gaining significant value in pharmaceutical as well as clinical applications to treat obscure oncological and rare maladies.

Antimicrobial Peptides Market: Drivers and Restraints

The cost of manufacturing antimicrobial peptides is more than the cost of manufacturing other pharmaceuticals for therapeutic utility depending on the target specificity. The business model for antimicrobial peptides is different than what is present in the pharmaceutical market owing to the novelty of the assays and techniques implemented.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-10249

The research process and designing the therapy process for commercialization is different, moreover the industry requires a more vigorous approach in order to create an entry and further access to the developing markets. Manufacturers of the antimicrobial peptides dependent therapy spend the majority their resources on upgrading the associated technology. The opportunities present in developing antimicrobial peptides are more as compared to threats prevalent. The application of antimicrobial peptides in ailment of Hepatitis C, pneumonia, bacterial infections, HIV AIDS and cancer is expected to surge the acceptance towards the therapies. The institutional research is heavily invested with rising pool of scientists and skilled technocrats interested in the domain for novel drugs involving antimicrobial peptides for rare diseases. The one of the pluses that include are antimicrobial peptides can be developed for a range of utilities ranging from increasing the shelf-life in food packaging to delivery of bioactive compounds in therapeutic sectors driving the market. The growing antibiotic resistance, synthetic approaches, innovative formulations and drug delivery routes are the factors expected to drive the growth.

Antimicrobial Peptides Market: Overview

The global market for antimicrobial peptides is estimated to experience a significant growth due to the increase in awareness and access towards drugs and therapies involving antimicrobial peptides. Chronic diseases where antibiotic resistance is not fruitful creates a more lucrative opportunity for manufactures present in the antimicrobial peptides market. The current structure of the antimicrobial peptides market include drugs targeted towards pneumonia, Hepatitis C, HIV and bacterial infections. Each of the antimicrobial peptides uses different type of mechanism and are used to deliver better clinical results.

Antimicrobial Peptides Market: Regional Outlook

Geographically, the Antimicrobial Peptides market is segmented into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania and Middle East and Africa. Each country is equally important to drive the market for antimicrobial peptides, advanced or emerging healthcare settings help in restoring the market and increase the reach to a wider section of patients in need. The distribution channel is an important part for antimicrobial peptides; the developed markets focus on the applications wherein the antimicrobial resistance is compromised whereas the emerging markets are more focused towards the reach and affordability of antimicrobial peptides. The North America region is estimated to have a significant share in the antimicrobial peptides market, owing to its quality infrastructure supporting the need of antimicrobial peptides research activities undertaken. It is followed by Europe, East Asia and Oceania. The South Asia antimicrobial peptides market would translate as a lucrative market opportunity for manufacturers, as well as industry experts, with present change in adoption and growth in general pharmaceutical market.

The key players involved in the market of antimicrobial peptides market include Eli Lilly and Company, Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, EnBiotix Inc., Johnson & Johnson Services, Merck & Co., Alexion Pharmaceuticals, Inc., Melinta Therapeutics, Inc., and Vertex Pharmaceuticals, Inc. The present market structure of antimicrobial peptides is expected to change with efforts and research present in clinical phase.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-10249

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Injection through syringes is the best method of administration drugs to the animals. Although the purpose of an injection is to benefit the animal, if proper technique is not used an injection has the potential to do harm. Adoption and selection of syringes helps in administration of life saving medicines, injury of animals and feed a hungry.

The veterinary syringes are driving the market due to its performance and increasing healthcare needs of veterinary animals. With improvements in the technologies Veterinary Syringes have become easy to use. Also they require less stress to animal keepers and provide accurate and quick results. Use of Veterinary Syringes help in managing various diseases by accurate dosing of the drugs. Also diet, exercise and regular veterinary checkups are important to improve the health of animals. With the rising adoption and increasing research & development and continuous efforts by the manufactures, the growth of Veterinary Syringes is expected to grow in the future.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-10238

Veterinary Syringes are expected to drive the market with the increasing pet ownership and growing veterinary practices. According to the American Pet Products Manufactures Association (APPMA), United States holds 68% for pet ownership, which is expected to increase the market for veterinary syringes market. The use of syringes and medicines ensure healthy and long lives for pets.

Advancement in the technology has led to selection of animal health dosing syringes based on their size and treatment. Also increasing prevalence rate of diabetes in animals will increase the veterinary syringes market. However poorly injected products may not absorb properly in the body of animals and cause scar tissue, animal pain.

Also these veterinary syringes are inexpensive. To control diabetes successful therapy of insulin is required with accurate dosing which requires usage of veterinary syringes this is expected to further increase the demand for Veterinary Syringes. According to the American pet society approximately 1 in 300 adult dogs and 1 in 230 cats in the US are suffering from diabetes which will also drive the Veterinary Syringes market.

Geographically, the Veterinary Syringes Market is segmented into various regions such as Europe, North America, Asia-Pacific, Latin America, Japan and Middle East & Africa. United States in North America is expected to dominate the Veterinary Syringes Market globally, followed by Europe, due to increasing adoption of companion animals in the region. Further, the availability of advanced products helps in managing the disease of the animals which is expected to boost the market Veterinary Syringes in the region. The veterinary syringes provide effective results for diabetes care which can increase the pet’s life.

The Veterinary Syringes Market in Asia Pacific is expected to grow at a higher rate due to adoption of animals which will increase the usage of Veterinary Syringes. In addition, countries such as India and China are expected to witness higher revenue growth during the forecast period.

Some of the major players in the Veterinary Syringes Market are Giordano Poultry Plast S.p.a., Hubert De backer nv, Intervet Inc., Nordson Corporation, Neogen Animal Safety, Becton, Dickinson and Company, genia, ThaMa-Vet Terumo Medical Corporation, SOL-Millennium, EXELINT among others. Moreover, the manufacturers and the producers are mainly focusing on strengthening the core competencies of their product portfolio.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-10238

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Electronic tongue is a device which measures and compares tastes. Electronic tongue is also called e-tongue. Electronic tongue equipped with multiple sensors which detect dissolved organic and inorganic compounds. Electronic tongue applies pattern recognition method to predict the taste of the sample. Electronic tongue has several application in various industries areas such as the pharmaceutical industry, food and beverage industry, and the healthcare industry. In the pharmaceutical industry, electronic tongue can be used for assessment of API bitterness strength and quantify bitterness of masking material. Electronic tongue is used to better adherence and improvement of taste of drugs for paediatric and geriatric patient base. Pharmaceutical companies have introduced the taste sensing systems for better development of paediatric and geriatric formulation. Electronic tongue is entered into medical diagnostic market and provide non-invasive disease diagnosis.  The electronic tongue has used to detect and identify a wide array of disorders including mental health disorders and metabolic disorder by analyzing both liquid and vapour patient sample. Electronic tongue systems such as biomimetic cross-reactive sensor array are affordable and efficient for medical diagnosis.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-9409

Electronic Tongue Market: Drivers and Restraints-

Electronic tongue market is expected to accounts for a significant growth rate as technological advancement in the medical industry. Increasing demand for advanced and non-invasive diagnosis devices expected to favor the growth of the electronic tongue market. Growing research and development for new drugs manufacturing expected propel the growth of the electronic tongue market over the forecast period. Increasing adoption of advanced technologies and devices in pharmaceutical manufacturing units expected to ample the growth of the electronic tongue market. Increasing government funding for drug development and medical diagnosis producers advancement expected to boost up the growth of the electronic tongue market. Growing development of new devices and sensors for tastes assessment of dissolved organic and inorganic compounds favors the growth of the electronic tongue market.

Electronic Tongue Market: Overview

Electronic tongue market expected to grow with the significant growth rate over the forecast period as increasing demand for the electronic tongue in the pharmaceutical industry. Electronic tongue performs taste masking assessment and provide objective results.  Electronic tongue performs taste assessment in a way similar to the human tongue. Electronic tongue analyzed sensory features such as the taste of drugs which is a key element in pharmaceutical product sales.  Electronic tongue also detects gustatory components metallic, astringent and pungent with basic tastes such as sweet, bitter, salty, sour and umami.  Electronic tongue enables pharmaceutical scientist to perform experiments without human safety consideration. Electronic tongue simplified the sensory test procedure for drug bitterness measurement.

Electronic Tongue Market: Region-wise Outlook

In terms of geography, the electronic tongue market has been divided into seven regions including Western Europe, North- America, Latin America, Eastern Europe, Japan, Middle-East & Africa, and Asia- Pacific excluding & Japan (APEJ). North America is expected to contribute the highest revenue share in the electronic tongue market as an increasing number of drug development and API formulation testing. Western European expected to contribute the second largest revenue followed by North America in electronic tongue market. Western Europe electronic tongue market expected to grow with major growth rate as increasing demand for advanced medical diagnostic devices. The Asia Pacific excluding Japan electronic tongue market is expected to grow with the highest growth rate over the forecast period due to increasing healthcare expenditure and growing investments in pharmaceutical developments.

Electronic Tongue Market: Key Market Participants

Example of companies participants in global electronic tongue market recognize across the value chain are Higuchi Inc., Norlab, Alpha MOS, TheSmartTongue, AFB International, Blonder Tongue Laboratories, Inc. and others. Manufactures are focusing on development of customized electronic tongue devices for medical and pharmaceutical industry.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-9409

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Visualisation in medical diagnosis is vital to detect diseases and to decide the healing technique. Endoscopes have been used since ages, however, chip-on-the-tip endoscopes have put foot in the endoscopes market and revolutionized the technique to endoscopy. Chip-on-the-tip endoscopes is a handheld miniature device with camera, as the name suggests, situated at the tip of the chip-on-the-endoscope. These cameras produce a high-dimensional image with greater pixel quality and sharpness to aid precise visualization of the structures inside the body. Chip-on-the-tip endoscopes allow minimally invasive surgeries with least opening in the body and good resolution video on the screen to assist the surgeon during surgery. Advance technology in microelectronics as well as compact image sensors have made chip-on-the-tip endoscopes feasible. Chip-on-the-tip endoscopes allow quick diagnosis compared to any other endoscopic instrument and enable visualisation of very fine structures through high quality image. Chip-on-the-tip endoscopes are also called as flexible endoscopes as they do not need to be adjusted, aligned or focussed unlike fibre-optic endoscopes. Adding to the list of advantages of chip-on-the-tip endoscopes are the compact design, biocompatible integration and cost-efficient and long-life.

Chip-on-the-Tip Endoscopes: Market Dynamics

The key factors contributing to the growth of the global chip-on-the-tip endoscopes market include rising adoption of chip-on-the-tip endoscopes for diagnostic applications, increasing application in minimally invasive surgeries. Availability of high-resolution and high-dimensional visualization equipment such as camera lens and HD-screens also propel the demand for chip-on-the-tip endoscopes. The rising awareness about minimally invasive surgeries and better patient outcome also contribute to the expansion of chip-on-the-tip endoscope market. Precise navigation and visualization which is essential in microsurgeries at complex structures is attained with the chip-on-the-tip endoscope future fueling the market. The expensive nature of the device can be considered as a restraint for adoption of the endoscopes.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-7994

Chip-on-the-Tip Endoscopes: Overview

Exponential growth in the chip-on-the-tip endoscope market is estimated due to increasing technological advances in high-dimensional real-time visualization technology. The expansion of the concerned market is also largely dependent on the increasing number of endoscopic and minimally invasive surgeries performed. Based on the product type, chip-on-the-tip endoscopes market has been segmented into rhinoscopes, laryngoscopes, bronchoscopes, gastroscopes, colonoscopies, arthroscopes, ureteroscope and others. Single-use segment holds a maximum share of global chip-on-the-tip endoscopes market on the basis of usage. The end users of the device are segmented as hospitals, diagnostic/imaging centers, ambulatory surgical centres, endoscopy facilities and clinics.

Chip-on-the-Tip Endoscopes: Region-wise Outlook

On the basis of geography, the global chip-on-the-tip endoscope market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa.The North America market holds the largest revenue share, rising adoption of the chip-on-the-tip endoscopes for diagnostic applications as well as endoscopic surgeries and high healthcare expenditure in North America. Europe accounts for the second large revenue share in the global chip-on-the-tip endoscopes market, owing to increasing adoption of the device, presence of many manufactures and improved healthcare facilities. Asia Pacific is predicted to witness rapid growth, owing to increasing technological advances are presence of local manufacturers.  China is expected to register significant growth, owing to numerous players in the market and adoption of latest technology by the end users. Latin America and Middle East & Africa are projected to exhibit slow growth in chip-on-the-tip endoscopes market, owing to the high cost nature of the product.

Chip-on-the-Tip Endoscopes: Key Players

Examples of some of the key players present in the global chip-on-the-tip endoscopes market are Olympus Europa SE & Co. KG, Fujifilm, Serwell Medi Equip (P) Ltd, HOYA Corporation, Physik Instrumente (PI) GmbH & Co. KG, JEDMED, Amico Group, Happersberger otopront GmbH, Karl Storz SE & Co. KG, Ambu A/S, TOSHIBA CORPORATION, LLT MEDICAL, OmniVision Technologies, Inc., Boston Scientific Corporation among others.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-7994

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to a recent study by Future Market Insights (FMI), the GCC medical gloves market is reached US$ 145 Mn in 2020. With sales growing at a healthy 7.9% CAGR, the market valuation is set to reach US$ 340.3 Mn by 2031.

Modernization of lifestyles in GCC countries has resulted into a rise in elective surgeries which are not crucial for an individual to survive but have more of an optional nature. Elective surgeries like plastic surgery, liposuction, rhinoplasty, breast augmentation, breast reduction, blepharoplasty, etc. have been getting increasingly popular in countries like Dubai and other Gulf countries. These surgeries ultimately require a supply of necessary medical supplies including medical gloves, thereby increasing their demand.

When performing any type of surgeries, chances of glove punctures while using single set of gloves are high. Therefore, professionals use double set of gloves to avoid the possibility of contamination of sterile surgical equipment. These “double gloving” practices are expected to continue boosting sales over the assessment period.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GC-1943

Key Takeaways:

• By raw material, the latex material segment is expected to hold 80.2% of the total market share in 2021, expanding at 7.9% CAGR during the forecast period.
• Based on product type, the examination gloves segment is projected to command 55.6% of total sales in 2021, expanding at 8.1% CAGR.
• By form, the powdered form segment is expected to hold 63.7% of the total market share in 2021, expanding at 8.0% CAGR.
• By type of use, sales of disposable gloves are anticipated to hold 90.5% of the total market share 2021, and are to projected to increase at a robust 8.0% CAGR over the forecast period.
• By end use, hospitals will account for 67.2% of total sales in 2021.
• By distribution channel, the direct selling channel will account for 55.1% of the total market share in 2021.
• Kingdom of Saudi Arabia (KSA) is anticipated to hold the largest share of 76.2% of the GCC medical gloves market in 2021.

Who is winning?

Leading players operating in the market are investing in mergers, acquisitions and collaborations with existing players and healthcare institutes to gain a competitive edge. For instance:

In August 2020, Ansell Healthcare Products LLC collaborated with Nordic company ONeMEd with an aim to expand their customer base in the Nordic countries. Ansell is one of the global leaders in hand protection equipment.

The key market players covered by FMI include Paul Hartmann AG,Hotpack Packaging Industries LLC,Falcon (Falcon Pack),Deeko Bahrain,Salalah Medical Supplies Mfg. Co. LLC,United Medical Industries,NAFA Enterprises Ltd.,Liberty Industries, Inc.,Ansell Healthcare,Mckesson Corporation,Cardinal Health, Inc.,Medline Indsutries, Inc.,Dynarex Corporation,Top Glove Corporation Berhad,Kimberly-Clark Corporation,Semperit AG Holding

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gc-1943

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Global hypercalcemia treatment market revenues are anticipated to reach US$ 9.64 Bn in 2017, up from US$ 7.86 Bn in 2015. Increasing prevalence of hyperparathyroidism-related hypercalcemia and rising incidence of multiple myeloma are major factors expected to fuel growth of the global hypercalcemia treatment market over the forecast period. Availability of drug therapy alternatives over surgeries and favourable reimbursement policies are key factors expected to fuel global market growth.

Hospitals remain the largest distribution channel in the hypercalcemia market in terms of revenue contribution, accounting for around 39% share to the global market in 2015. Rapid diagnosis and easy availability of hypercalcemia drugs are key factors attributed to increasing revenue from the hospitals end user segment, and hospitals are expected to continue to remain the largest distribution channel for hypercalcemia treatment in the long-term.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1320

Bisphosphonates product type segment is estimated to continue to account for relatively higher revenue share to the global market, at over 67% in 2016 end. U.S. FDA approval of denosumab (Xgeva) for treating hypercalcemia of malignancy refractory in 2014 has boosted the use of biophosphonates. Glucocorticoids and calcimimetics segments are also anticipated to witness steady revenue growth in the near future.

North America and Western Europe are among the leading markets for hypercalcemia treatment, with the former accounting for revenue share of 46% in 2015. The North America hypercalcemia treatment market is anticipated to be valued at US$ 4.39 Bn in 2017, up from US$ 3.61 Bn in 2015. The market in North America is dominated by the U.S. Higher prevalence of malignancy-related hypercalcemia among cancer patients in North America will continue to influence market growth in the near future.

Amgen Inc., Novartis AG, and Teva Pharmaceuticals Industries Ltd., Pfizer Inc., and F.Hoffmann-La Roche Ltd. are among the leading players in the global hypercalcemia market. The U.S. remains a lucrative market for majority of leading players; foraying into emerging markets of Asia and Africa is a key focus area for global players.

Long-term Outlook: The global hypercalcemia market is anticipated to register a CAGR of 11.2% in terms of revenue during forecast period 2016–2026, and reach a value of US$ 25.23 Bn by 2026.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1320

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to a recent study by Future Market Insights (FMI), the global balloon catheter market is expected to witness high growth during the forecast period. Sales are expected to reach US$ 5.11 Bn by the end of 2031. This reflects a cumulative CAGR of around 4.0% over the forecast period (2021-2031).

Drug eluting balloons are playing an important role by facilitating the push mechanism, through the drug treatment. Excipient coated balloons offer a high efficacy and viability for the transfer of the drug.

Development in such technologies is increasing the use of balloon catheters, boosting the market. Hence, to gain competitive edge, key players are developing advanced drug eluting balloon.

Subsequently, these companies are getting approvals from the governments to commercially manufacture these balloons. This is expected to bode well for the growth in the market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1916

Furthermore, due to prolonged stay at the hospital in angioplasty procedures, preference for the same is decreasing among patients with coronary artery disease (CAD). Hence, with attributes such as minimal invasion of drug eluting balloon catheters, demand is increasing among CAD patients.

Hence, efforts are being taken by public authorities, NGO’s, and government to spread awareness regarding the positive benefits of balloon catheters. For instance, campaigns such as “Spread the Word Campaign”, educating women on CAD and its treatments solutions by Healthy Women and National Association for Nurse Practitioners.

A slew of such activities are expected to increase the demand for balloon catheters over the forecast period.

Key Takeaways

• By product, normal balloon catheter holds the maximum share of 43.9% in 2021, expanding at 0.8% CAGR during the forecast period.
• By indication, coronary artery disease is anticipated to account for nearly 71.5% market share in terms of value due to the high prevalence of coronary artery diseases across the globe
• By raw material, the nylon segment holds 46.3% of the market share, registering 4.0% CAGR  in 2021
• Polyurethane catheters are expected to hold second-largest share, contributing 34% of overall sales in 2021.
• By end user, the hospital segment will account for 70.5% of the market share in 2021 due to the availability of advanced technology and need for minimally invasive surgical procedures.
• By region, North America held the largest share of 31.7% in the global Balloon Catheter market in 2021.

Who is winning?

Some of the leading manufacturers of balloon catheters market are focusing on product launches for expansion of their product portfolio. They are also aiming for strategic mergers and partnerships, thereby, strengthening their global presence.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1916

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

The global special purpose needles market is projected to be valued at US$ 17,261.5 million by the end of 2026, registering a CAGR of 7.4% during the forecast period (2016–2026). In a new report titled “Special Purpose Needles Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”, Future Market Insights delivers key insights on the factors and trends impacting the global special purpose needles market over a 10-year forecast period (2016–2026).

The market for special purpose needles is witnessing steady growth across the globe owing to an increasing geriatric population. According to analysts at Future Market Insights, “Increasing prevalence of diabetes and infectious diseases and increasing incidence of cancer and spine disorders across the globe are the primary factors driving the growth of the global special purpose needles market.” Availability of better reimbursement options for some types of special purpose needles in developed economies is likely to propel demand for special purpose needles over the forecast period. A key trend witnessed in the global special purpose needles market is the development of advanced techniques in the production of special purpose needles to facilitate enhanced patient safety and comfort. However, rise in awareness on needle free injections and risks associated with injections are major factors expected to hamper the overall growth of the special purpose needles market over the forecast period.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-583

The global special purpose needles market can be segmented on the basis of product type (Fine Aspirating Needles, Biopsy Needles, Hypodermic Needles, Pen Needles, Suture Needles, IV Catheter Needles, Implantation Needles, Dental Needles, Ophthalmic Needles, Blood Collection Needles, Spinal Anaesthesia Needles, Epidural Needles, AV Fistula Needles, Cannula Needles); application (Sample Collection, Drug Delivery); and distribution channel (Hospital Pharmacies, Private Clinics,   Retail Pharmacies and Drug Stores, E-Commerce).

Segmentation highlights

• The Pen Needles product type segment is expected to gain popularity over the forecast period, driven by increasing global adoption of small sized needles for insulin injections. The Pen Needles product type segment is estimated to reach a valuation of US$ 644.3 Mn by the end of 2016, registering a CAGR of 9.1% over the forecast period.
• The Sample Collection application segment is estimated to register a CAGR of 7.7% while the Drug Delivery application segment is expected to register a CAGR of 7.1% during the forecast period.
• Demand for special purpose needles over the forecast period is expected to be the highest in the Hospital Pharmacies distribution channel segment, which is expected to register a CAGR of 8.5% in terms of value.

Regional forecast

The North America market has been estimated to dominate the special purpose needles market while the market in APEJ is expected to be the fastest growing in terms of revenue growth. The markets in North America, Western Europe, and APEJ are estimated to collectively hold 74.7% market share of the global special purpose needles market in 2016.

Vendor insights

Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, Terumo Corporation, Smiths Medical, Boston Scientific Corporation, Novo Nordisk A/S, Argon Medical Devices, Inc., Stryker Corporation, NIPRO Medical Corporation, Cook Medical, and SERAG-WIESSNER GmbH & Co. are some of the major companies operating in the global special purpose needles market. These companies are adopting innovative strategies to bring in improvements to their product design and are initiating advanced R&D activities and market consolidation to strengthen market foothold and expand customer base.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-583

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com